Skip to main content
Top
Published in: Diabetologia 11/2015

01-11-2015 | Article

Caesarean section per se does not increase the risk of offspring developing type 1 diabetes: a Swedish population-based study

Authors: Ulf Samuelsson, Nina Lindell, Marie Bladh, Karin Åkesson, Annelie Carlsson, Ann Josefsson

Published in: Diabetologia | Issue 11/2015

Login to get access

Abstract

Aims/hypothesis

Some studies have revealed a relationship between Caesarean section (CS) and type 1 diabetes, while other studies have not. By using the Swedish paediatric quality register we investigated whether birth by CS is related to the risk of developing type 1 diabetes during childhood.

Methods

All children diagnosed with type 1 diabetes from 2000 to 2012 and included in the register (n = 9,376) were matched with four controls by year, day of birth, sex and county of birth from the Swedish Medical Birth Register.

Results

Overall, 13.5% of deliveries were by CS. By group, 14.7% of children who developed type 1 diabetes were delivered by CS compared with 13.3% of control children (p < 0.001). Mothers with diabetes more often gave birth by CS than mothers without diabetes (78.8% vs 12.7%, p < 0.001). In a logistic regression model adjusting for maternal age, maternal diabetes and BMI in early pregnancy, the OR for CS was 1.0. A child who developed type 1 diabetes and had a mother with type 1 diabetes at the time of delivery had the highest OR to have been born by CS. Children of mothers without diabetes, delivered by CS, had no increased risk of developing type 1 diabetes. Maternal diabetes was the strongest predictor of childhood diabetes (OR 3.4), especially if the mother had type 1 diabetes (OR 7.54).

Conclusions/interpretation

CS had no influence on the risk of type 1 diabetes during childhood or adolescence. However, maternal diabetes itself strongly increased the risk of offspring developing type 1 diabetes.
Literature
1.
go back to reference Diamond Project Group (2006) Incidence and trends of childhood type 1 diabetes worldwide 1990–1999. Diabet Med 23:857–866CrossRef Diamond Project Group (2006) Incidence and trends of childhood type 1 diabetes worldwide 1990–1999. Diabet Med 23:857–866CrossRef
2.
go back to reference Taplin CE, Craig ME, Lloyd M et al (2005) The rising incidence of childhood type 1 diabetes in New South Wales, 1990–2002. Med J Aust 183:243–246PubMed Taplin CE, Craig ME, Lloyd M et al (2005) The rising incidence of childhood type 1 diabetes in New South Wales, 1990–2002. Med J Aust 183:243–246PubMed
4.
go back to reference Thomas J, Paranjothy S, Royal College of Obstetricians and Gynaecologists Clinical Effectiveness Support Unit (2001) National Sentinel Caesarean Section audit report. RCOG Press, London Thomas J, Paranjothy S, Royal College of Obstetricians and Gynaecologists Clinical Effectiveness Support Unit (2001) National Sentinel Caesarean Section audit report. RCOG Press, London
6.
go back to reference Hamilton BE, Martin JA, Sutton PD (2004) Births: preliminary data for 2003. Natl Vital Stat Rep 53:1–18PubMed Hamilton BE, Martin JA, Sutton PD (2004) Births: preliminary data for 2003. Natl Vital Stat Rep 53:1–18PubMed
7.
go back to reference Betrán AP, Merialdi M, Lauer JA et al (2007) Rates of caesarean section: analysis of global, regional and national estimates. Paediatr Perinat Epidemiol 28:98–113CrossRef Betrán AP, Merialdi M, Lauer JA et al (2007) Rates of caesarean section: analysis of global, regional and national estimates. Paediatr Perinat Epidemiol 28:98–113CrossRef
9.
go back to reference Field LL (2002) Genetic linkage and association studies of type I diabetes: challenges and rewards. Diabetologia 45:21–35CrossRefPubMed Field LL (2002) Genetic linkage and association studies of type I diabetes: challenges and rewards. Diabetologia 45:21–35CrossRefPubMed
10.
go back to reference Dahlquist GG, Patterson C, Soltesz G (1999) Perinatal risk factors for childhood type 1 diabetes in Europe. The EURODIAB Substudy 2 Study Group. Diabetes Care 22:1698–1702CrossRefPubMed Dahlquist GG, Patterson C, Soltesz G (1999) Perinatal risk factors for childhood type 1 diabetes in Europe. The EURODIAB Substudy 2 Study Group. Diabetes Care 22:1698–1702CrossRefPubMed
11.
go back to reference Cardwell CR, Stene LC, Joner G et al (2008) Caesarean section is associated with an increased risk of childhood-onset type 1 diabetes mellitus: a meta-analysis of observational studies. Diabetologia 51:726–7354CrossRefPubMed Cardwell CR, Stene LC, Joner G et al (2008) Caesarean section is associated with an increased risk of childhood-onset type 1 diabetes mellitus: a meta-analysis of observational studies. Diabetologia 51:726–7354CrossRefPubMed
12.
go back to reference Khashan AS, Kenny LC, Lundholm C, Kearney PM, Gong T, Almqvist C (2014) Mode of obstetrical delivery and type 1 diabetes: a sibling design study. Pediatrics 134:e806–e813CrossRefPubMed Khashan AS, Kenny LC, Lundholm C, Kearney PM, Gong T, Almqvist C (2014) Mode of obstetrical delivery and type 1 diabetes: a sibling design study. Pediatrics 134:e806–e813CrossRefPubMed
14.
go back to reference Algert CS, McElduff A, Morris JM, Roberts C (2009) Perinatal risk factors for early onset of type 1 diabetes in a 2000–2005 birth cohort. Diabet Med 26:1193–1197PubMedCentralCrossRefPubMed Algert CS, McElduff A, Morris JM, Roberts C (2009) Perinatal risk factors for early onset of type 1 diabetes in a 2000–2005 birth cohort. Diabet Med 26:1193–1197PubMedCentralCrossRefPubMed
15.
go back to reference Stene LC, Magnus P, Lie RT, Sovik O, Joner G, the Norwegian Childhood Diabetes Study Group (2003) No association between pre-eclampsia or caesarean section and incidence of type 1 diabetes among children: a large population-based cohort study. Pediatr Res 54:487–490CrossRefPubMed Stene LC, Magnus P, Lie RT, Sovik O, Joner G, the Norwegian Childhood Diabetes Study Group (2003) No association between pre-eclampsia or caesarean section and incidence of type 1 diabetes among children: a large population-based cohort study. Pediatr Res 54:487–490CrossRefPubMed
16.
go back to reference Bache I, Bock T, Volund A, Buschard K (1999) Previous maternal abortion, longer gestation, and younger maternal age decrease the risk of type diabetes among male offspring. Diabetes Care 22:1063–1065CrossRefPubMed Bache I, Bock T, Volund A, Buschard K (1999) Previous maternal abortion, longer gestation, and younger maternal age decrease the risk of type diabetes among male offspring. Diabetes Care 22:1063–1065CrossRefPubMed
17.
go back to reference Stene LC, Magnus P, Lie RT, Sovik O, Joner G, the Norwegian Childhood Diabetes Study Group (2001) Maternal and paternal age at delivery, birth order, and risk of childhood onset type 1 diabetes: population based cohort study. BMJ 323:1–4CrossRef Stene LC, Magnus P, Lie RT, Sovik O, Joner G, the Norwegian Childhood Diabetes Study Group (2001) Maternal and paternal age at delivery, birth order, and risk of childhood onset type 1 diabetes: population based cohort study. BMJ 323:1–4CrossRef
18.
go back to reference Stene LC, Gale EAM (2013) The prenatal environment and type 1 diabetes. Diabetologia 56:1888–1897CrossRefPubMed Stene LC, Gale EAM (2013) The prenatal environment and type 1 diabetes. Diabetologia 56:1888–1897CrossRefPubMed
19.
go back to reference Warram JH, Krolewski AS, Gottlieb MS, Kahn CR (1984) Differences in risk of insulin-dependent diabetes in offspring of diabetic mothers and diabetic fathers. NEJM 311:149–152CrossRefPubMed Warram JH, Krolewski AS, Gottlieb MS, Kahn CR (1984) Differences in risk of insulin-dependent diabetes in offspring of diabetic mothers and diabetic fathers. NEJM 311:149–152CrossRefPubMed
20.
go back to reference Lorenzen T, Pociot F, Stilgren L et al (1998) Predictors of IDDM recurrence risk in offspring of Danish IDDM patients. Danish IDDM Epidemiology and Genetics Group. Diabetologia 41:666–673CrossRefPubMed Lorenzen T, Pociot F, Stilgren L et al (1998) Predictors of IDDM recurrence risk in offspring of Danish IDDM patients. Danish IDDM Epidemiology and Genetics Group. Diabetologia 41:666–673CrossRefPubMed
21.
go back to reference Harjutsalo V, Reunanen A, Tuomilehto J (2006) Differential transmission of type 1 diabetes from diabetic fathers and mothers to their offspring. Diabetes 55:1517–1524CrossRefPubMed Harjutsalo V, Reunanen A, Tuomilehto J (2006) Differential transmission of type 1 diabetes from diabetic fathers and mothers to their offspring. Diabetes 55:1517–1524CrossRefPubMed
22.
go back to reference Bonifacio E, Pflüger M, Marienfeld S, Winkler C, Hummel M, Ziegler A-G (2008) Maternal type 1 diabetes reduces the risk of islet autoantibodies: relationships with birthweight and maternal HbA1c. Diabetologia 51:1245–1252CrossRefPubMed Bonifacio E, Pflüger M, Marienfeld S, Winkler C, Hummel M, Ziegler A-G (2008) Maternal type 1 diabetes reduces the risk of islet autoantibodies: relationships with birthweight and maternal HbA1c. Diabetologia 51:1245–1252CrossRefPubMed
23.
go back to reference Nielsen GL, Moller M, Sorensen HAT (2006) HbA1c in early pregnancy and pregnancy outcomes: a Danish population-based cohort study of 573 pregnancies in woman with type 1 diabetes. Diabetes Care 29:2612–2616CrossRefPubMed Nielsen GL, Moller M, Sorensen HAT (2006) HbA1c in early pregnancy and pregnancy outcomes: a Danish population-based cohort study of 573 pregnancies in woman with type 1 diabetes. Diabetes Care 29:2612–2616CrossRefPubMed
24.
go back to reference Lindsay RS, Walker JD, Halsall I et al (2003) Scottish multicentre study of diabetes in pregnancy. J Clin Endocrinol Metab 88:1664–1671CrossRefPubMed Lindsay RS, Walker JD, Halsall I et al (2003) Scottish multicentre study of diabetes in pregnancy. J Clin Endocrinol Metab 88:1664–1671CrossRefPubMed
25.
go back to reference Min Y, Lowy C, Ghebremeskel K, Thomas B, Offley-Shore B, Crawford M (2005) Unfavorable effect of type 1 and type 2 diabetes on maternal and fetal essential fatty acid status: a potential marker of fetal insulin resistance. Am J Clin Nutr 82:1162–1168PubMed Min Y, Lowy C, Ghebremeskel K, Thomas B, Offley-Shore B, Crawford M (2005) Unfavorable effect of type 1 and type 2 diabetes on maternal and fetal essential fatty acid status: a potential marker of fetal insulin resistance. Am J Clin Nutr 82:1162–1168PubMed
26.
go back to reference Gronlund MM, Lethonen OP, Eerola E, Kero P (1999) Fecal microflora in healthy infants born by different methods of delivery: permanent changes in intestinal flora after cesarean delivery. J Pediatr Gastroenterol 28:19–25CrossRef Gronlund MM, Lethonen OP, Eerola E, Kero P (1999) Fecal microflora in healthy infants born by different methods of delivery: permanent changes in intestinal flora after cesarean delivery. J Pediatr Gastroenterol 28:19–25CrossRef
28.
go back to reference Penders J, Thijs C, Vink C et al (2006) Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 118:511–521CrossRefPubMed Penders J, Thijs C, Vink C et al (2006) Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 118:511–521CrossRefPubMed
29.
go back to reference Salminen S, Gibson GR, McCartney AL, Isolauri E (2010) Influence of mode of delivery on gut microbiota in seven-year-old children. Gut 107:11971–11975 Salminen S, Gibson GR, McCartney AL, Isolauri E (2010) Influence of mode of delivery on gut microbiota in seven-year-old children. Gut 107:11971–11975
Metadata
Title
Caesarean section per se does not increase the risk of offspring developing type 1 diabetes: a Swedish population-based study
Authors
Ulf Samuelsson
Nina Lindell
Marie Bladh
Karin Åkesson
Annelie Carlsson
Ann Josefsson
Publication date
01-11-2015
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 11/2015
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-015-3716-3

Other articles of this Issue 11/2015

Diabetologia 11/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine